A Study to Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of [14C]-BMS-986504 (MRTX1719) in Participants With Advanced Solid Tumors With Homozygous Methylthioadenosine Phosphorylase Deletion

NCT06672523 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors With Homozygous MTAP Deletion

Interventions

DRUG: BMS-986504
DRUG: [14C]-BMS-986504

Sponsor

Bristol-Myers Squibb